Compounds > ezetimibe
Page last updated: 2024-09-04

ezetimibe and Cancer of Prostate

ezetimibe has been researched along with Cancer of Prostate in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Habe, K; Higashiyama, A; Mizutani, H; Omoto, Y; Yamanaka, K; Yokoyama, T1
Alfaqih, MA; Barry, WT; Dambal, SK; Dewhirst, MW; Freedland, AR; Freedland, SJ; Freeman, MR; Macias, E; Masko, EM; Muehlbauer, MJ; Newgard, CB; Phillips, TE; Pizzo, SV; Poulton, SH; Sanders, SE; Solomon, KR; Sun, S; Valilis, NA1
Boucher, K; Freeman, MR; Joo, J; Kim, J; Pelton, K; Schaffner, CP; Solomon, KR; Tully, C; Zurakowski, D1
Jeon, TI; Osborne, TF; Seo, YK; Zhu, B1

Other Studies

4 other study(ies) available for ezetimibe and Cancer of Prostate

ArticleYear
Flutamide-induced photoleukomelanoderma.
    The Journal of dermatology, 2016, Volume: 43, Issue:9

    Topics: Administration, Cutaneous; Aged; Androgen Antagonists; Benzimidazoles; Biopsy; Biphenyl Compounds; Bisoprolol; Clopidogrel; Drug Eruptions; Eicosapentaenoic Acid; Ezetimibe; Flutamide; Glucocorticoids; Humans; Male; Patch Tests; Photosensitivity Disorders; Prostatic Neoplasms; Skin Pigmentation; Sunlight; Tetrazoles; Ticlopidine; Ursodeoxycholic Acid; Withholding Treatment

2016
Evidence for Feedback Regulation Following Cholesterol Lowering Therapy in a Prostate Cancer Xenograft Model.
    The Prostate, 2017, Volume: 77, Issue:5

    Topics: Animals; Anticholesteremic Agents; Cell Line, Tumor; Cell Proliferation; Cholesterol; Drug Therapy, Combination; Ezetimibe; Feedback, Physiological; Humans; Male; Mice; Mice, Nude; Prostatic Neoplasms; Simvastatin; Tumor Burden; Xenograft Model Antitumor Assays

2017
Ezetimibe is an inhibitor of tumor angiogenesis.
    The American journal of pathology, 2009, Volume: 174, Issue:3

    Topics: Animals; Anticholesteremic Agents; Antineoplastic Agents; Apoptosis; Azetidines; Cell Death; Cholesterol; Ezetimibe; Hemoglobins; Humans; Male; Mice; Microcirculation; Neoplasm Transplantation; Neovascularization, Pathologic; Prostatic Neoplasms; Transplantation, Heterologous

2009
Regulation of steroid 5-alpha reductase type 2 (Srd5a2) by sterol regulatory element binding proteins and statin.
    Experimental cell research, 2009, Nov-01, Volume: 315, Issue:18

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Animals; Atorvastatin; Azetidines; Cell Line, Tumor; Ezetimibe; Gene Expression Regulation, Enzymologic; Heptanoic Acids; Hydroxymethylglutaryl CoA Reductases; Hypercholesterolemia; Liver; Lovastatin; Male; Mice; Promoter Regions, Genetic; Prostate; Prostatic Neoplasms; Pyrroles; Sterol Regulatory Element Binding Protein 2; Transfection

2009